- Investing Ideas
- /
- Swedish Pharmaceuticals & Biotech Fast Growing Stocks With High Insider Ownership
Swedish Pharmaceuticals & Biotech Fast Growing Stocks With High Insider Ownership
Results
11
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
11 companies
Xbrane Biopharma
Market Cap: SEK 410.6m
A biotechnology company, engages in the development, manufacture, and sale of biosimilars.
XBRANE
SEK 0.27
7D
12.7%
1Y
17.8%
Bonesupport Holding
Market Cap: SEK 21.4b
An orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally.
BONEX
SEK 325.20
7D
9.6%
1Y
9.9%
Guard Therapeutics International
Market Cap: SEK 407.4m
A pharmaceutical company, identifies, develops, and commercializes therapies for the diagnosis and treatment of acute kidney injuries in Sweden.
GUARD
SEK 19.10
7D
0.5%
1Y
-34.6%
Devyser Diagnostics
Market Cap: SEK 2.2b
Engages in the development, manufacture, and sale of diagnostic kits and solutions for DNA testing within hereditary diseases, oncology, and post-transplantation monitoring in Sweden, rest of Europe, the Middle East, Africa, North and South America, and Asia.
DVYSR
SEK 132.00
7D
1.1%
1Y
21.1%
Klaria Pharma Holding AB (publ.)
Market Cap: SEK 83.7m
A pharmaceutical company develops and commercializes medication for migraine and cancer related pain, and opioid overdose and anaphylactic shock.
KLAR
SEK 0.58
7D
4.7%
1Y
67.0%
SynAct Pharma
Market Cap: SEK 1.1b
A clinical stage biotechnology company, researches and develops medicines for the treatment of inflammatory diseases in Sweden.
SYNACT
SEK 20.85
7D
-4.6%
1Y
147.6%
Diamyd Medical
Market Cap: SEK 1.3b
Develops precision medicine therapies for the treatment of autoimmune diabetes.
DMYD B
SEK 9.70
7D
2.4%
1Y
-31.5%
Egetis Therapeutics
Market Cap: SEK 2.0b
A pharmaceutical company, focuses on projects in late-stage development for the treatment of serious diseases with unmet medical needs in the orphan drug segment.
EGTX
SEK 5.43
7D
15.4%
1Y
-8.7%
Mendus
Market Cap: SEK 404.2m
A biopharmaceutical company, develops immunotherapies for the treatment of tumor recurrence and established tumors.
IMMU
SEK 7.59
7D
1.7%
1Y
-8.1%
Genovis AB (publ.)
Market Cap: SEK 1.8b
Develops and sells tools for the development of new treatment methods and diagnostics in North America, Europe, and Asia.
GENO
SEK 26.45
7D
-4.9%
1Y
-7.0%
Swedencare
Market Cap: SEK 7.4b
Develops, manufactures, markets, and sells animal healthcare products for cats, dogs, and horses in North America, Europe, and internationally.
SECARE
SEK 48.30
7D
4.3%
1Y
-7.0%